James has served as the General Counsel of Janux Therapeutics since July 2021, where he manages the legal aspects of corporate governance, public company and securities compliance, finance, employment, and complex commercial transactions. Prior to Janux, James had more than 17 years of experience as a corporate and securities lawyer with Cooley LLP, where his practice focused primarily on biotechnology companies. While at Cooley, James managed a wide range of financing, M&A and collaboration transactions.
James received a J.D., cum laude, from the University of San Diego School of Law, an LL.M. in Securities and Financial Regulation, with distinction, from Georgetown University Law Center, and a B.A. from the University of California, Los Angeles.